UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): June 16, 2010 (June 14, 2010)
Rexahn Pharmaceuticals, Inc.
(Exact Name of Issuer as Specified in Charter)

DELAWARE
 
001-34079
 
11-3516358
(State or Other Jurisdiction of Incorporation or Organization)
 
(Commission File Number)
 
(I.R.S. Employer Identification Number)

15245 Shady Grove Road, Suite 455
 
20850
Rockville, MD
 
(Zip Code)
(Address of Principal Executive Offices)
 
 

(240) 268-5300
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
 


 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.
 
Rexahn Pharmaceuticals, Inc. (the “Company”) held its annual meeting of stockholders on June 14, 2010.  At the meeting, the Company’s stockholders (i) elected each of the Board’s nominees to serve as directors of the Company until the 2011 annual meeting of stockholders, or until their successors are duly elected and qualified, and (ii) ratified the selection of ParenteBeard LLC as the Company's independent registered public accounting firm for the 2010 fiscal year.

The final number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes, with respect to each matter is set forth below.

   
For
   
Against
   
Withheld
   
Abstained
   
Broker Non-Votes
 
                               
1. Election of Directors
                             
                               
Chang H. Ahn
    40,795,497       202,209       -       1,553,963       13,715,536  
Charles Beever
    40,571,965       211,962       -       1,767,742       13,715,536  
Kwang Soo Cheong
    40,589,136       194,509       -       1,768,024       13,715,536  
Tae Heum Jeong
    40,583,686       200,259       -       1,767,724       13,715,536  
David McIntosh
    40,602,340       181,587       -       1,767,742       13,715,536  
                                         
2. Ratification of the selection of ParenteBeard LLC as the Company's independent registered public accounting firm for the 2010 fiscal year.
    54,002,411       447,528       -       1,817,266       -  

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Rexahn Pharmaceuticals, Inc.
 
     
Date: June 16, 2010
By: 
/s/ Tae Heum Jeong
 
 
 
Name: 
Tae Heum Jeong
 
 
 
Title: 
Chief Financial Officer